Published in Clin Exp Allergy on April 01, 2010
Diversity and dialogue in immunity to helminths. Nat Rev Immunol (2011) 3.72
CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue. J Leukoc Biol (2015) 1.49
Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov (2013) 1.47
The expanding role(s) of eosinophils in health and disease. Blood (2012) 1.35
Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol (2014) 1.24
Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J Immunol (2011) 1.22
Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". J Allergy Clin Immunol (2012) 1.16
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol (2012) 1.12
Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol (2014) 1.08
Eosinophilic inflammation in allergic asthma. Front Pharmacol (2013) 1.00
Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development. Nat Immunol (2013) 0.93
Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am J Pathol (2011) 0.93
CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis. Mucosal Immunol (2013) 0.91
Update on clinical and immunological features of eosinophilic gastrointestinal diseases. Curr Opin Gastroenterol (2011) 0.91
Roles and regulation of gastrointestinal eosinophils in immunity and disease. J Immunol (2014) 0.91
Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clin Exp Allergy (2014) 0.91
Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder. Urol Oncol (2013) 0.90
Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity? J Innate Immun (2011) 0.90
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat (2013) 0.90
Changing roles of eosinophils in health and disease. Ann Allergy Asthma Immunol (2014) 0.89
Integrin activation States and eosinophil recruitment in asthma. Front Pharmacol (2013) 0.89
Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest (2016) 0.88
Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice. Allergy (2013) 0.88
Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. Int J Parasitol (2014) 0.87
High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One (2015) 0.85
Eosinophilic bioactivities in severe asthma. World Allergy Organ J (2016) 0.82
Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice. Allergy (2015) 0.80
Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. Annu Rev Pathol (2016) 0.80
Loss of hypoxia-inducible factor 2 alpha in the lung alveolar epithelium of mice leads to enhanced eosinophilic inflammation in cobalt-induced lung injury. Toxicol Sci (2013) 0.79
Environmental exposures and airway inflammation in young thoroughbred horses. J Vet Intern Med (2014) 0.79
Anti-IL5 therapy for asthma and beyond. World Allergy Organ J (2014) 0.79
The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review. J Asthma Allergy (2015) 0.77
Eosinophils: important players in humoral immunity. Clin Exp Immunol (2015) 0.77
Probing the immune and healing response of murine intestinal mucosa by time-lapse 2-photon microscopy of laser-induced lesions with real-time dosimetry. Biomed Opt Express (2014) 0.77
Interaction between allergy and innate immunity: model for eosinophil regulation of epithelial cell interferon expression. Ann Allergy Asthma Immunol (2013) 0.77
Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women's Health Study. Mod Pathol (2016) 0.76
SiglecF+Gr1hi eosinophils are a distinct subpopulation within the lungs of allergen-challenged mice. J Leukoc Biol (2016) 0.76
Dendritic cells, macrophages, NK and CD8(+) T lymphocytes play pivotal roles in controlling HSV-1 in the trigeminal ganglia by producing IL1-beta, iNOS and granzyme B. Virol J (2017) 0.75
Cyclophilin D regulates necrosis, but not apoptosis, of murine eosinophils. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer. Curr Allergy Asthma Rep (2012) 0.75
Eosinophil peroxidase activates cells by HER2 receptor engagement and β1-integrin clustering with downstream MAPK cell signaling. Clin Immunol (2016) 0.75
Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus. J Immunol (2017) 0.75
Novel CLC3 transcript variants in blood eosinophils and increased CLC3 expression in nasal lavage and blood eosinophils of asthmatics. Immun Inflamm Dis (2014) 0.75
Transcriptome profiling of mouse colonic eosinophils reveals a key role for eosinophils in the induction of s100a8 and s100a9 in mucosal healing. Sci Rep (2017) 0.75
Lung Pathologies in a Chronic Inflammation Mouse Model are Independent of Eosinophil Degranulation. Am J Respir Crit Care Med (2016) 0.75
Caspofungin Increases Fungal Chitin and Eosinophil and γδ T Cell-Dependent Pathology in Invasive Aspergillosis. J Immunol (2017) 0.75
Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease. J Exp Med (2017) 0.75
Frontline Science: Eosinophil-deficient MBP-1 and EPX double-knockout mice link pulmonary remodeling and airways dysfunction with type 2 inflammation. J Leukoc Biol (2017) 0.75
White Blood Cell Subtypes Are Associated with a Greater Long-Term Risk of Death after Acute Myocardial Infarction. Tex Heart Inst J (2017) 0.75
The Biology of Eosinophils and Their Role in Asthma. Front Med (Lausanne) (2017) 0.75
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer (2009) 18.53
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell (2003) 15.43
Broad phylogenomic sampling improves resolution of the animal tree of life. Nature (2008) 11.84
Mesenchymal stem cells in health and disease. Nat Rev Immunol (2008) 11.14
Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med (2009) 8.36
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
The eosinophil. Annu Rev Immunol (2006) 7.06
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med (2009) 5.90
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med (2008) 4.93
Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol (1992) 4.92
Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity (2004) 4.81
Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol (2000) 3.27
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
The gastrointestinal tract stem cell niche. Stem Cell Rev (2006) 2.73
Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest (1980) 2.70
The role of stromal stem cells in tissue regeneration and wound repair. Science (2009) 2.51
Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet (1982) 2.21
The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol (2004) 2.13
Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med (2008) 2.11
Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol (2006) 2.06
Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol (2004) 2.05
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med (2002) 2.04
Tumour-associated eosinophilia: a review. J Clin Pathol (1981) 2.03
Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res (2002) 1.90
A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2009) 1.85
Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol (2008) 1.79
Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol (2007) 1.78
T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol Rev (1988) 1.76
Homeostasis of effector systems which can also be recruited for immunologic reactions. J Immunol (1978) 1.74
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med (1990) 1.71
Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68
Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med (1996) 1.67
A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol (2003) 1.65
Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur J Immunol (1987) 1.62
Do eosinophils have a role in the killing of helminth parasites? Parasitol Today (2000) 1.61
Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit Care (2004) 1.57
CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med (2009) 1.56
Eosinophils in asthma--closing the loop or opening the door? N Engl J Med (2009) 1.49
Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. FASEB J (2008) 1.43
Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol (2004) 1.42
Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood (2006) 1.42
Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol (2001) 1.40
Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother (2007) 1.39
BLOOD CELL FORMATION AND DISTRIBUTION IN RELATION TO THE MECHANISM OF THYROID-ACCELERATED METAMORPHOSIS IN THE LARVAL FROG. J Exp Med (1923) 1.39
Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Mol Cell Endocrinol (2008) 1.38
The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today (2000) 1.37
Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J Immunol (2000) 1.37
Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol (2007) 1.36
Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J Immunol (2007) 1.30
Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J Allergy Clin Immunol (2001) 1.30
Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol (2009) 1.30
Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol (2005) 1.28
Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy (2008) 1.26
Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis (2007) 1.25
Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation (2009) 1.22
A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol (1996) 1.16
CD11c+ eosinophils in the murine thymus: developmental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J Immunol (2000) 1.12
Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum Mol Genet (2008) 1.11
Eosinophil ablation and tumor development. Oral Oncol (1999) 1.02
Eotaxin is required for eosinophil homing into the stroma of the pubertal and cycling uterus. Endocrinology (2001) 1.01
Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J Immunol (1999) 1.01
A role for eosinophils in transplant rejection. Trends Immunol (2001) 0.95
Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis. J Innate Immun (2009) 0.92
Degranulating eosinophils in human endometriosis. Am J Pathol (2000) 0.92
Depletion of eosinophil infiltration by anti-IL-5 monoclonal antibody (TRFK-5) accelerates open skin wound epithelial closure. Am J Pathol (1997) 0.90
The role of eosinophil major basic protein in angiogenesis. Allergy (2008) 0.90
Evidence for secretion of human eosinophil granule major basic protein and Charcot-Leyden crystal protein during eosinophil maturation. Exp Hematol (1984) 0.87
Allergen-induced, eotaxin-rich, proangiogenic bone marrow progenitors: a blood-borne cellular envoy for lung eosinophilia. J Allergy Clin Immunol (2010) 0.86
Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni. Immunology (1990) 0.84
Eosinophil infiltration and degranulation in normal human tissues: evidence for eosinophil degranulation in normal gastrointestinal tract. Int Arch Allergy Immunol (2001) 0.83
Eosinophilopoiesis at the cross-roads of research on development, immunity and drug discovery. Curr Med Chem (2007) 0.83
Eosinophils and Trichinella infection: toxic for the parasite and the host? Trends Parasitol (2008) 0.81
The role of eosinophils in the pathophysiology of asthma. Ann N Y Acad Sci (1991) 0.80
Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response. Cell Transplant (1999) 0.77
Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol (1986) 3.41
Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30
Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun (1998) 1.87
Mouse models of Hermansky Pudlak syndrome: a review. Pigment Cell Res (1998) 1.83
Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol (1999) 1.83
Human lung mast cells: purification and characterization. J Immunol (1982) 1.78
Generation of leukotrienes by purified human lung mast cells. J Clin Invest (1982) 1.77
Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol (1988) 1.68
IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol (1995) 1.68
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy (2001) 1.63
Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol (2000) 1.61
Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol (2000) 1.52
Arachidonic acid metabolism in purified human lung mast cells. J Immunol (1984) 1.47
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol (2000) 1.46
Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol (1991) 1.45
Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? Clin Exp Allergy (2005) 1.44
Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol (2001) 1.42
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest (1983) 1.41
Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol (2001) 1.40
Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol (1994) 1.38
Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol (1992) 1.38
Heterogeneity of human mast cells. J Immunol (1983) 1.37
Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J Immunol (2000) 1.37
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol (1995) 1.33
Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study. Neurology (2004) 1.32
Recombinant IL-3 induces histamine release from human basophils. J Immunol (1989) 1.31
Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood (1995) 1.30
Cloning of the murine eosinophil peroxidase gene (mEPO): characterization of a conserved subgroup of mammalian hematopoietic peroxidases. J Leukoc Biol (1996) 1.24
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest (1997) 1.22
Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol (1991) 1.21
Lymphoid cell dependence of eosinophil response to antigen. J Exp Med (1971) 1.21
Chemokines and allergic disease. J Allergy Clin Immunol (1999) 1.20
Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Proc Natl Acad Sci U S A (1996) 1.19
Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis. Allergy (2012) 1.18
Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J Immunol (2000) 1.16
Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis (1994) 1.15
Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology (1992) 1.14
Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol (1999) 1.14
Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis (1982) 1.14
Inhibition of basophil histamine release by anti-inflammatory steroids. Nature (1981) 1.14
The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol (1994) 1.12
Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol (1997) 1.12
Comparative studies of human basophils and mast cells. Fed Proc (1983) 1.11
Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol (1988) 1.11
Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem (1992) 1.10
Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev (2001) 1.10
Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J Immunol (1998) 1.09
Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery (1999) 1.08
Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. J Immunol (1994) 1.07
Pilomatrix carcinoma with multiple metastases: report of a case and review of the literature. Eur J Cancer (1999) 1.07
Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation. J Cell Biol (1984) 1.07
CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am J Respir Cell Mol Biol (1998) 1.06
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol (1986) 1.05
Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol (1996) 1.05
Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis (1984) 1.05
Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1. Am J Respir Cell Mol Biol (1997) 1.03
Identification of a new murine eosinophil major basic protein (mMBP) gene: cloning and characterization of mMBP-2. J Leukoc Biol (2000) 1.02
Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol (1985) 1.02
Immature dense granules in platelets from mice with platelet storage pool disease. Blood (1987) 1.01
Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis (1986) 1.01
Imaging findings in schwannomas of the jugular foramen. AJNR Am J Neuroradiol (2000) 1.01
Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol (1991) 1.01
Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol (2001) 1.01
Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol (2001) 1.00
Flow cytometric methods for the analysis of human basophil surface antigens and viability. J Immunol Methods (1989) 1.00
Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol (1996) 0.99
Human lung macrophages enhance and inhibit lymphocyte proliferation. J Immunol (1984) 0.98
Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. J Immunol (1982) 0.98
Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol (1990) 0.98
Modulation of MHC class II expression in human cells by dexamethasone. Cell Immunol (1995) 0.98
The identification and cloning of a murine major basic protein gene expressed in eosinophils. J Immunol (1995) 0.98
Mouse eosinophil-associated ribonucleases: a unique subfamily expressed during hematopoiesis. Mamm Genome (2001) 0.97
Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J Immunol (1991) 0.97
Adherence of human basophils to cultured umbilical vein endothelial cells. J Clin Invest (1988) 0.96
Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells. Clin Exp Allergy (2004) 0.96
Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest (2001) 0.96
Inhibition of T cell-mediated cytotoxicity by anti-inflammatory steroids. J Immunol (1984) 0.95
Preliminary identification and role of phosphodiesterase isozymes in human basophils. J Immunol (1992) 0.95
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest (1987) 0.95
Inherited thrombocytopenia caused by reduced platelet production in mice with the gunmetal pigment gene mutation. Blood (1995) 0.95
Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response. J Immunol (1981) 0.95
Abnormal vesicular trafficking in mouse models of Hermansky-Pudlak syndrome. Pigment Cell Res (2000) 0.95
Spleen cells from Schistosoma mansoni-infected mice produce diffusible stimulator of eosinophilopoiesis in vivo. Nature (1976) 0.95
Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids. J Immunol (1987) 0.94
Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophils. Blood (1993) 0.94
Variation in dinucleotide (GT) repeat sequence in the first exon of the STAT6 gene is associated with atopic asthma and differentially regulates the promoter activity in vitro. J Med Genet (2004) 0.94
Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis (1989) 0.94
Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps. Clin Exp Allergy (2014) 0.93
Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther (1991) 0.93
Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am J Respir Cell Mol Biol (1999) 0.93
Qualitative differences between dimeric and trimeric stimulation of human basophils. J Immunol (1983) 0.93
The mechanisms of antiinflammatory steroid action in allergic diseases. Annu Rev Pharmacol Toxicol (1985) 0.92
Elastase and cathepsin G activities are present in immature bone marrow neutrophils and absent in late marrow and circulating neutrophils of beige (Chediak-Higashi) mice. J Exp Med (1987) 0.92
IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils. J Immunol (1990) 0.91
Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab Invest (1985) 0.91